Tango Therapeutics Inc (TNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2009 | 12-2008 | 12-2007 | |
| Cash Flows From Operating Activities | |||
| Net Income | -2,554 | -6,959 | -9,735 |
| Depreciation Amortization | 3,729 | 2,762 | 1,943 |
| Income taxes - deferred | 190 | 62 | N/A |
| Accounts receivable | -141 | -1,596 | -1,040 |
| Accounts payable and accrued liabilities | 113 | 392 | 708 |
| Other Working Capital | 116 | 727 | 2,545 |
| Other Operating Activity | 978 | 3,350 | 777 |
| Operating Cash Flow | $2,431 | $-1,263 | $-4,803 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -660 | -671 | -513 |
| Net Acquisitions | -70 | -12,051 | -1,979 |
| Other Investing Activity | 0 | -1,375 | 0 |
| Investing Cash Flow | $-730 | $-14,096 | $-2,492 |
| Cash Flows From Financing Activities | |||
| Debt Issued | 0 | 16,690 | -2,388 |
| Debt Repayment | -1,476 | -3,240 | 6,135 |
| Common Stock Issued | 77 | 137 | 334 |
| Common Stock Repurchased | N/A | -4,605 | N/A |
| Other Financing Activity | -693 | 11,550 | -263 |
| Financing Cash Flow | $-2,092 | $20,533 | $3,818 |
| Beginning Cash Position | 6,554 | 1,381 | 4,858 |
| End Cash Position | 6,163 | 6,554 | 1,381 |
| Net Cash Flow | $-391 | $5,173 | $-3,477 |
| Free Cash Flow | |||
| Operating Cash Flow | 2,431 | -1,263 | -4,803 |
| Capital Expenditure | -660 | -671 | -513 |
| Free Cash Flow | 1,771 | -1,934 | -5,315 |